© 2022 MJH Life Sciences™ and Contemporary Pediatrics. All rights reserved.
ADHD
Do preschool children with ADHD get the behavioral therapy they need?
April 24, 2022
At the 2022 Pediatric Academic Societies meeting, Shruti Mittal, MD, FAAP, looked at how many children with attention-deficit/hyperactivity disorder get started on behavioral therapy before medication in the preschool years.
Newest medications for ADHD
March 23, 2022
At the 43rd National Conference on Pediatric Health Care for nurse practitioners in Dallas, Texas, a look at the newest medications for children with attention-deficit/hyperactivity disorder.
ADHD highlights from the 2022 ASPARD meeting
February 22, 2022
Catch up on all the latest in ADHD from the The American Professional Society of ADHD (attention-deficit/hyperactivity disorder) and Related Disorders (APSARD) virtual 2022 Annual Meeting.
FDA approves Dyanavel XR for ADHD treatment in kids 6 and older
November 05, 2021
In a clinical study of healthy adults, Dyanavel XR tablets were deemed to be bioequivalent to amphetamine extended-release oral suspension in patients with attention-deficit/hyperactivity disorder (ADHD) by the US Food and Drug Administration (FDA).
My child won't sit still! Is it ADHD, or an underlying sleep disorder?
October 09, 2021
At the virtual 2021 American Academy of Pediatrics National Conference & Exhibition, Grace Wang, MD, FAAP, discusses how treatment of underlying sleep disorders can improve ADHD symptomatology.
Prenatal exposure to analgesic opioid linked with elevated risk of ADHD
October 05, 2021
A study has found that prenatal analgesic opioid exposure of 5 or more weeks is associated with a slightly elevated risk of attention-deficit/hyperactivity disorder (ADHD) in children compared to exposure of 4 weeks or less.
AZSTARYS is now available for treating ADHD
July 22, 2021
AZSTARYS (serdexmethylphenidate and dexmethylphenidate) is available for prescription to help provide rapid and extended duration of attention-deficit/hyperactivity disorder (ADHD) symptoms.
Participation in after-school activities decreases ADHD severity
July 01, 2021
A study examines the effect of after-school activity participation on a child's attention-deficit/hyperactivity disorder (ADHD) severity.
Study examines alternatives for preschool ADHD medications
June 09, 2021
Stimulants are recommended as the first-line treatment for attention-deficit/hyperactivity disorder (ADHD). A study examines whether α2-adrenergic agonists could be effective as well.